WBA stock price: Walgreens beats on revenue in one of its last earnings reports as a public company
Shares in Walgreens Boots Alliance, Inc. (Nasdaq: WBA) are trading slightly higher this morning after the company reported its Q2 2025 earnings results. The results, which beat on earnings and revenue, are notable as they will be one of the last earnings results the company posts as a publicly traded company. Here’s what you need to know about Walgreens’ results.
Walgreens shares trading higher after Q2 2025 results
As of the time of this writing, WBA shares are up about 1.72% in early-morning trading. The price rise likely reflects the fact that much of the markets are up today—a first in the last three trading days since President Trump announced his chaotic tariffs on countries around the world on April 2.
However, WBA stock is also likely rising slightly today due to the fact that the company posted beats on revenue and earnings for its second quarter of fiscal 2025.
For the second quarter, Walgreens Boots Alliance announced revenues of $38.6 billion—a 4.1% increase from the same quarter a year ago. The company also announced an adjusted earnings per share (EPS) of 63 cents—down from an adjusted EPS of $1.20 in the quarter a year earlier.
Walgreens said that the EPS decline was due to several factors, including “prior year adjusted effective tax benefit, lower U.S. retail sales and prior year sale-leaseback gains, partly offset by cost savings within U.S. Retail Pharmacy and growth in U.S. Healthcare.”
As noted by CNBC, despite the disappointing EPS, Walgreens still managed to beat analyst expectations. Analysts had expected an EPS of just 53 cents and revenue of $38 billion.
No fiscal 2025 guidance
One notable absence from Walgreens’ Q2 2025 numbers was its fiscal guidance for the rest of the financial year. The company removed its previous FY25 guidance because it is being taken private.
Last month, private equity firm Sycamore Partners agreed to buy the struggling pharmacy chain for $11.45 per share. That transaction is scheduled to conclude in the final quarter of the 2025 calendar year, pending regulatory and other approvals.
Walgreens had previously said in January that it had expected a full-year 2025 EPS of between $1.40 and $1.80 per share. However, in its press release for its Q2, Walgreens stated that “WBA’s previously issued guidance for full year fiscal 2025 should no longer be relied upon.”
Walgreens stock price down from 12-month highs
Given that Sycamore Partners has already agreed to buy Walgreens Boots Alliance for $11.45 per share, it’s no wonder that the company’s stock price has fluctuated little since the deal was announced last month. As a matter of fact, until Trump’s tariff announcements last week, WBA stock had been relatively steady since the deal was announced.
However, primarily due to global stock markets crashing in the past several days, WBA stock is currently still down about 4.7% in the past month.
WBA stock is also down significantly from where it was a year ago, when it traded at over $19 per share. Since its January 2024 highs, WBA shares have fallen over 43%.